The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Perry Michael S since year 2005.
The trader's CIK number is 1250379.
At the time of the last reporting, Perry Michael S was the Director of Arrowhead Pharmaceuticals, Inc. .
(stock ticker symbol ARWR).
See this page for all insider trading activities at Arrowhead Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-09-09||ARWR||Arrowhead Pharmaceuticals, Inc.||Sale||100,000||28.90||2,890,000|
|2019-09-11||ARWR||Arrowhead Pharmaceuticals, Inc.||Sale||85,000||30.00||2,550,000|
|2018-03-22||APHB||Ampliphi Biosciences Corp||Buy||181,820||1.10||200,002|
|2017-06-29||APHB||Ampliphi Biosciences Corp||Buy||5,757||.00||0|
|2017-09-19||APHB||Ampliphi Biosciences Corp||Buy||105,015||.00||0|
|2012-03-26||PARD||Neorx Corp||Option Ex||2,800||.00||0|
|2012-02-15||PARD||Neorx Corp||Option Ex||12,019||.00||0|
|2011-04-09||PARD||Neorx Corp||Option Ex||112,000||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Perry Michael S (Director of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.